EPO reduces reactive gliosis and stimulates neurotrophin expression in Muller cells

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 4, 2011, Pages 1541-1555

  Hu, Liu Mei ^a   Luo, Yan ^a   Zhang, Jingfa ^b,c   Lei, Xia ^c   Shen, Jianfeng ^c   Wu, Yalan ^c   Qin, Mei ^a   Unver, Yaprak Banu ^d   Zhong, Yong ^a   Xu, Guo Tong ^b,c   Li, Weiye ^a,b,c,e  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Beyoglu Eye Training and Research Hospital   (Turkey)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetic retinopathy; Erythropoietin; Gliosis; MAPK ERK; M ller cells; Neurotrophin; PI3K

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIC FACTOR; NEUROTROPHIN; PROTEIN KINASE B; VIMENTIN; NERVE GROWTH FACTOR; PRIMER DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE TIME EFFECT RELATION; DOWN REGULATION; GLIOSIS; IN VITRO STUDY; MALE; MUELLER CELL; NERVE DEGENERATION; NERVE FIBER GROWTH; NERVE REGENERATION; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; PROTEIN EXPRESSION; RAT; RETINA NERVE CELL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RETINA; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

RATTUS;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; NERVE GROWTH FACTORS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RETINA; VIMENTIN;

EID: 80053613637     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. E. L. Fletcher, J. A. Phipps and J. L. Wilkinson-Berka: Dysfunction of retinal neurons and glia during diabetes. Clin Exp Optom, 88(3), 132-45 (2005)
2. Q. Li, E. Zemel, B. Miller and I. Perlman: Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res, 74(5), 615-25 (2002) (Pubitemid 34757017)
3. M. Mizutani, C. Gerhardinger and M. Lorenzi: Muller cell changes in human diabetic retinopathy. Diabetes, 47(3), 445-9 (1998) (Pubitemid 28104208)
4. E. L. Fletcher, J. A. Phipps, M. M. Ward, T. Puthussery and J. L. Wilkinson-Berka: Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des, 13(26), 2699-712 (2007) (Pubitemid 47423662)
5. E. L. Fletcher, L. E. Downie, A. Ly, M. M. Ward, A. H. Batcha, T. Puthussery, P. Yee and K. M. Hatzopoulos: A review of the role of glial cells in understanding retinal disease. Clin Exp Optom, 91(1), 67-77 (2008)
6. K. Shinoda, R. Rejdak, F. Schuettauf, G. Blatsios, M. Volker, N. Tanimoto, T. Olcay, F. Gekeler, C. Lehaci, R. Naskar, Z. Zagorski and E. Zrenner: Early electroretinographic features of streptozotocin-induced diabetic retinopathy. Clin Experiment Ophthalmol, 35(9), 847-54 (2007)
7. A. Bringmann, T. Pannicke, J. Grosche, M. Francke, P. Wiedemann, S. N. Skatchkov, N. N. Osborne and A. Reichenbach: Muller cells in the healthy and diseased retina. Prog Retin Eye Res, 25(4), 397-424 (2006) (Pubitemid 44038611)
8. A. Bringmann and A. Reichenbach: Role of Muller cells in retinal degenerations. Front Biosci, 6, E72-92 (2001)
9. A. Bringmann and P. Wiedemann: Involvement of Muller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol, 247(7), 865-83 (2009)
10. N. Byts and A. L. Siren: Erythropoietin: a multimodal neuroprotective agent. Exp Transl Stroke Med, 1, 4 (2009)
11. S. Genc, T. F. Koroglu and K. Genc: Erythropoietin and the nervous system. Brain Res, 1000(1-2), 19-31 (2004) (Pubitemid 38446486)
12. T. Rabie and H. H. Marti: Brain protection by erythropoietin: a manifold task. Physiology (Bethesda), 23, 263-74 (2008)
13. C. E. King, J. Rodger, C. Bartlett, T. Esmaili, S. A. Dunlop and L. D. Beazley: Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol, 205(1), 48-55 (2007) (Pubitemid 46617489)
14. J. Zhang, Y. Wu, Y. Jin, F. Ji, S. H. Sinclair, Y. Luo, G. Xu, L. Lu, W. Dai, M. Yanoff, W. Li and G. T. Xu: Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci, 49(2), 732-42 (2008)
15. E. Kilic, U. Kilic, J. Soliz, C. L. Bassetti, M. Gassmann and D. M. Hermann: Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J, 19(14), 2026-8 (2005) (Pubitemid 41759753)
16. A. L. Siren, M. Fratelli, M. Brines, C. Goemans, S. Casagrande, P. Lewczuk, S. Keenan, C. Gleiter, C. Pasquali, A. Capobianco, T. Mennini, R. Heumann, A. Cerami, H. Ehrenreich and P. Ghezzi: Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A, 98(7), 4044-9 (2001) (Pubitemid 32249895)
17. Z. Z. Chong, F. Li and K. Maiese: Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during betaamyloid toxicity. Curr Neurovasc Res, 2(5), 387-99 (2005) (Pubitemid 41789605)
18. A. Muller, T. G. Hauk, M. Leibinger, R. Marienfeld and D. Fischer: Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol Cell Neurosci, 41(2), 233-46 (2009)
19. B. Viviani, S. Bartesaghi, E. Corsini, P. Villa, P. Ghezzi, A. Garau, C. L. Galli and M. Marinovich: Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J Neurochem, 93(2), 412-21 (2005) (Pubitemid 40547498)
20. L. Wang, Z. Zhang, Y. Wang, R. Zhang and M. Chopp: Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke, 35(7), 1732-7 (2004) (Pubitemid 38823656)
21. V. P. Sarthy, S. J. Brodjian, K. Dutt, B. N. Kennedy, R. P. French and J. W. Crabb: Establishment and characterization of a retinal Muller cell line. Invest Ophthalmol Vis Sci, 39(1), 212-6 (1998) (Pubitemid 28040483)
22. J. Shen, Y. Wu, J. Y. Xu, J. Zhang, S. H. Sinclair, M. Yanoff, G. Xu, W. Li and G. T. Xu: ERK-and Aktdependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci, 51(1), 35-46 (2010)
23. R. Wang, Y. H. Li, Y. Xu, Y. B. Li, H. L. Wu, H. Guo, J. Z. Zhang, J. J. Zhang, X. Y. Pan and X. J. Li: Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry, 34(1), 147-53 (2010)
24. A. E. West, W. G. Chen, M. B. Dalva, R. E. Dolmetsch, J. M. Kornhauser, A. J. Shaywitz, M. A. Takasu, X. Tao and M. E. Greenberg: Calcium regulation of neuronal gene expression. Proc Natl Acad Sci U S A, 98(20), 11024-31 (2001) (Pubitemid 32928677)
25. Q. Mohamed, M. C. Gillies and T. Y. Wong: Management of diabetic retinopathy: a systematic review. JAMA, 298(8), 902-16 (2007) (Pubitemid 47311296)
26. H. Mansour, C. G. Chamberlain, M. W. Weible, 2nd, S. Hughes, Y. Chu and T. Chan-Ling: Aging-related changes in astrocytes in the rat retina: imbalance between cell proliferation and cell death reduces astrocyte availability. Aging Cell, 7(4), 526-40 (2008) (Pubitemid 351998613)
27. V. Asnaghi, C. Gerhardinger, T. Hoehn, A. Adeboje and M. Lorenzi: A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes, 52(2), 506-11 (2003) (Pubitemid 36173210)
28. L. Zhong, J. Bradley, W. Schubert, E. Ahmed, A. P. Adamis, D. T. Shima, G. S. Robinson and Y. S. Ng: Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci, 48(3), 1212-8 (2007) (Pubitemid 351261416)
29. M. Garcia-Ramirez, C. Hernandez and R. Simo: Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care, 31(6), 1189-94 (2008)
30. Z. Xie, X. Wu, Q. Qiu, Y. Gong, Y. Song, Q. Gu and C. Li: Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Curr Eye Res, 32(9), 757-64 (2007) (Pubitemid 47450627)
31. I. Yatsiv, N. Grigoriadis, C. Simeonidou, P. F. Stahel, O. I. Schmidt, A. G. Alexandrovitch, J. Tsenter and E. Shohami: Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J, 19(12), 1701-3 (2005) (Pubitemid 41429535)
32. Y. Shen, H. M. Yu, T. M. Yuan, W. Z. Gu and Y. D. Wu: Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra-uterine infection. Neuropathology, 29(5), 528-35 (2009)
33. D. Agnello, P. Bigini, P. Villa, T. Mennini, A. Cerami, M. L. Brines and P. Ghezzi: Erythropoietin exerts an antiinflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res, 952(1), 128-34 (2002) (Pubitemid 35279495)
34. X. Lei, J. Zhang, J. Shen, L. M. Hu, Y. Wu, L. Mou, G. Xu, W. Li and G. T. Xu: EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Front Biosci in press (2010)
35. M. Seki, T. Tanaka, H. Nawa, T. Usui, T. Fukuchi, K. Ikeda, H. Abe and N. Takei: Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes, 53(9), 2412-9 (2004) (Pubitemid 39145597)
36. Y. Aizu, H. Katayama, S. Takahama, J. Hu, H. Nakagawa and K. Oyanagi: Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats. Neuroreport, 14(16), 2067-71 (2003)
37. E. J. Mufson, J. S. Kroin, T. J. Sendera and T. Sobreviela: Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol, 57(4), 451-84 (1999) (Pubitemid 29057112)
38. W. Duan, J. Lee, Z. Guo and M. P. Mattson: Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J Mol Neurosci, 16(1), 1-12 (2001) (Pubitemid 32402341)
39. J. C. Lauterborn, S. Rivera, C. T. Stinis, V. Y. Hayes, P. J. Isackson and C. M. Gall: Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. J Neurosci, 16(23), 7428-36 (1996) (Pubitemid 26389681)
40. A. Tabuchi, H. Sakaya, T. Kisukeda, H. Fushiki and M. Tsuda: Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem, 277(39), 35920-31 (2002)
41. T. Harada and C. Harada: [Function of glial cell network as a modulator of neural cell death during retinal degeneration]. Nippon Ganka Gakkai Zasshi, 108(11), 674-81 (2004)
42. A. P. Mizisin, Y. Vu, M. Shuff and N. A. Calcutt: Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes, 53(7), 1807-12 (2004) (Pubitemid 38857039)
43. M. H. Park, S. M. Lee, J. W. Lee, D. J. Son, D. C. Moon, D. Y. Yoon and J. T. Hong: ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin. Biochem Biophys Res Commun, 339(4), 1021-8 (2006) (Pubitemid 41790566)
44. N. Byts, A. Samoylenko, T. Fasshauer, M. Ivanisevic, L. Hennighausen, H. Ehrenreich and A. L. Siren: Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ, 15(4), 783-92 (2008) (Pubitemid 351405083)
45. F. B. Mehrhof, F. U. Muller, M. W. Bergmann, P. Li, Y. Wang, W. Schmitz, R. Dietz and R. Von Harsdorf: In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH- kinase-dependent and mitogenactivated protein kinase-dependent activation of the transcription factor cAMP response element-binding protein. Circulation, 104(17), 2088-94 (2001) (Pubitemid 33027051)
46. M. Fukuchi, A. Tabuchi and M. Tsuda: Transcriptional regulation of neuronal genes and its effect on neural functions: cumulative mRNA expression of PACAP and BDNF genes controlled by calcium and cAMP signals in neurons. J Pharmacol Sci, 98(3), 212-8 (2005) (Pubitemid 41296400)
47. Q. L. Fu, W. Wu, H. Wang, X. Li, V. W. Lee and K. F. So: Up-regulated endogenous erythropoietin/erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol, 28(2), 317-29 (2008) (Pubitemid 351253068)
48. G. Tezel and M. B. Wax: Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci, 20(23), 8693-700 (2000)
49. T. Nakazawa, T. Hisatomi, C. Nakazawa, K. Noda, K. Maruyama, H. She, A. Matsubara, S. Miyahara, S. Nakao, Y. Yin, L. Benowitz, A. Hafezi-Moghadam and J. W. Miller: Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A, 104(7), 2425-30 (2007) (Pubitemid 46391413)
50. K. Kashiwagi, Y. Iizuka, M. Araie, Y. Suzuki and S. Tsukahara: Effects of retinal glial cells on isolated rat retinal ganglion cells. Invest Ophthalmol Vis Sci, 42(11), 2686-94 (2001) (Pubitemid 32954881)
51. Q. Wang, F. Pfister, A. Dorn-Beineke, F. Vom Hagen, J. Lin, Y. Feng and H. P. Hammes: Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina. Diabetologia, 53(6), 1227-38 (2010)
52. Z. Y. Wang, K. K. Zhao and P. Q. Zhao: Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes. Med Hypotheses, 76(2), 266-8 (2011)
53. Z. Tong, Z. Yang, S. Patel, H. Chen, D. Gibbs, X. Yang, V. S. Hau, Y. Kaminoh, J. Harmon, E. Pearson, J. Buehler, Y. Chen, B. Yu, N. H. Tinkham, N. A. Zabriskie, J. Zeng, L. Luo, J. K. Sun, M. Prakash, R. N. Hamam, S. Tonna, R. Constantine, C. C. Ronquillo, S. Sadda, R. L. Avery, J. M. Brand, N. London, A. L. Anduze, G. L. King, P. S. Bernstein, S. Watkins, L. B. Jorde, D. Y. Li, L. P. Aiello, M. R. Pollak and K. Zhang: Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A, 105(19), 6998-7003 (2008) (Pubitemid 351754519)
54. A. M. Abu El-Asrar, L. Missotten and K. Geboes: Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes. Br J Ophthalmol, 91(6), 822-6 (2007) (Pubitemid 46846660)
55. J. C. Tsai: Safety of intravitreally administered recombinant erythropoietin (an AOS thesis). Trans Am Ophthalmol Soc, 106, 459-72 (2008)
56. J. F. Zhang, Y. L. Wu, J. Y. Xu, W. Ye, Y. Zhang, H. Weng, W. D. Shi, G. X. Xu, L. Lu, W. Dai, S. H. Sinclair, W. Y. Li and G. T. Xu: Pharmacokinetic and toxicity study of intravitreal erythropoietin in rabbits. Acta Pharmacol Sin, 29(11), 1383-90 (2008)
57. B. J. Song, H. Cai, J. C. Tsai, S. Chang, M. Forbes and L. V. Del Priore: Intravitreal recombinant human erythropoietin: a safety study in rabbits. Curr Eye Res, 33(9), 750-60 (2008)
58. W. A. Lagreze, N. Feltgen, M. Bach and T. Jehle: Feasibility of intravitreal erythropoietin injections in humans. Br J Ophthalmol, 93(12), 1667-71 (2009)
59. W. Li, S. H. Sinclair and G. T. Xu: Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema. Ophthalmic Surg Lasers Imaging, 41(1), 18-25 (2010)
60. J. Ben-nun, V. A. Alder and I. J. Constable: Retinal microvascular patency in the diabetic rat. Int Ophthalmol, 25(4), 187-92 (2004)